Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study
- PMID: 28614368
- PMCID: PMC5470687
- DOI: 10.1371/journal.pone.0179290
Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study
Abstract
Background: One of the major challenges in treating major depressive disorder (MDD) is patients' non-adherence to medication. This study aimed to explore the barriers and facilitators of patients' adherence to antidepressants among outpatients with MDD.
Methods: Semi-structured and individual in-depth interviews were conducted among patients with MDD who were taking antidepressants, in the psychiatric clinic of a government-run hospital in Malaysia. Participants were purposively sampled from different genders and ethnicities. Interviews were conducted using a validated topic guide, and responses were audio-recorded, transcribed verbatim, checked, and analyzed using the grounded theory approach.
Results: A total of 30 patients were interviewed. Forty different themes and sub-themes were identified which were conceptually divided into two distinct categories related to barriers and facilitators to adherence. The barriers were: patient-specific, medication-specific, healthcare provision and system, social-cultural, and logistics. The facilitators were: having insight, perceived health benefits, regular activities, patient-provider relationship, reminders, and social support networks.
Conclusions: Patient-specific barriers and medication side effects were the major challenges for adhering to treatment. Perceived health benefits and having insight on the need for treatment were the most frequently cited facilitators. Targeted interventions should be developed to address the key barriers, and promote measures to facilitate adherence in this group of patients.
Conflict of interest statement
References
-
- Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). The Journal of clinical psychiatry. 2015;76(2):155–62. Epub 2015/03/06. doi: 10.4088/JCP.14m09298. . - DOI - PubMed
-
- Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJL. Global burden of depressive disorders in the year 2000. The British Journal of Psychiatry. 2004;184(5):386–92. doi: 10.1192/bjp.184.5.386 - DOI - PubMed
-
- World Health Organization. World Health Report 2001. Mental Health. New Understanding, New Hope 2001 [cited 2014 30 October]. Available from: http://www.who.int/whr/2001/en/whr01_en.pdf?ua=1.
-
- Mathers CD, Loncar D. Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLoS Med. 2006;3(11):e442 doi: 10.1371/journal.pmed.0030442 - DOI - PMC - PubMed
-
- Mukhtar F, Oei P. A Review on the Prevalence of Depression in Malaysia. Current Psychiatry Reviews. 2011;7(3):234–8.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
